Radiation may shrink existing metastatic tumors not directly treated. New research shows the opposite effect: Such tumors may also grow.

Yet in its feverish purge of federal health programs, it has proposed eliminating the National Center for Chronic Disease Prevention and Health Promotion and its annual funding of $1.4 billion. That’s ...

The NIH's National Cancer Institute, which has long benefited from bipartisan support, now faces an exodus of clinicians and scientists.

Scientists at the National Institutes of Health (NIH) have found that two common types of hormone therapy may alter breast cancer risk in women before age 55. Researchers discovered that women treated ...

Researchers in Europe and the U.S. have long collaborated to tackle tough scientific questions. Certain fields, like rare diseases, particularly benefit from international collaboration because it ...

Women who used at-home test kits were more than twice as likely to complete screening than those who received only telephone reminders.

This week, the U.S. Senate approved President Donald Trump’s “big, beautiful” tax and spending bill. It includes more than $1 trillion in cuts to Medicaid, the joint state-federal health insurance ...

“These findings are concerning, especially as ICIs are being used more frequently in treating people with both early and late-stage cancers,” said Dr. Jingxuan Zhao, senior scientist, health services ...

Todd Heywood, known by his friends as simply “Heywood,” has been an outspoken HIV survivor, renowned investigative journalist, and queer advocate for most of his life. So it should come as no surprise ...

Watch a Melanoma Research Alliance presentation by Alexandra-Chloe Villani about immunotherapy side effects in this skin cancer.

Using data from the United States and the United Kingdom, scientists found that people with a higher intake of the amino acid lysine—particularly from eating red meat—faced a significantly greater ...

The Food and Drug Administration (FDA) has loosened restrictions on CAR-T therapies for blood cancers, a move that is expected to make the revolutionary immunotherapy available to more people in more ...